These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 21388245

  • 1. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
    Gurbuz C, Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V.
    J Endourol; 2011 May; 25(5):775-9. PubMed ID: 21388245
    [Abstract] [Full Text] [Related]

  • 2. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
    Espiritu PN, Sverrisson EF, Sexton WJ, Pow-Sang JM, Poch MA, Dhillon J, Spiess PE.
    Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
    [Abstract] [Full Text] [Related]

  • 3. Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
    Youssef RF, Shariat SF, Lotan Y, Cost N, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Chromecki TF, Montorsi F, Bolenz C, Margulis V.
    Urol Oncol; 2013 Jul; 31(5):676-81. PubMed ID: 21704538
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [Abstract] [Full Text] [Related]

  • 5. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [Abstract] [Full Text] [Related]

  • 6. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review.
    Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA.
    BJU Int; 2012 Sep; 110(5):614-28. PubMed ID: 22471401
    [Abstract] [Full Text] [Related]

  • 7. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Rink M, Soave A, Dahlem R, Aziz A, Al-Sayed F, Peine S, Engel O, Kluth LA, Stenzl A, Burger M, Shariat SF, Fisch M, Fritsche HM, Gakis G.
    Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
    [Abstract] [Full Text] [Related]

  • 8. Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
    Youssef RF, Lotan Y, Sagalowsky AI, Shariat SF, Wood CG, Raman JD, Langner C, Zigeuner R, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V.
    Int Braz J Urol; 2013 Feb; 39(5):614-21. PubMed ID: 24267122
    [Abstract] [Full Text] [Related]

  • 9. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
    Bagrodia A, Kuehhas FE, Gayed BA, Wood CG, Raman JD, Kapur P, Derweesh IH, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V.
    Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
    [Abstract] [Full Text] [Related]

  • 10. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G, Colin P, Zerbib M, Audenet F, Soulié M, Hurel S, Delage F, Irani J, Descazeaud A, Droupy S, Rozet F, Phé V, Ruffion A, Long JA, Crouzet S, Houlgatte A, Bigot P, Guy L, Faïs PO, Rouprêt M, French Collaborative National Database on UUT-UC.
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [Abstract] [Full Text] [Related]

  • 11. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Kosaka T, Oyama M, Miyajima A, Momma T, Nakagawa K, Jinzaki M, Nakajima Y, Oya M.
    Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429
    [Abstract] [Full Text] [Related]

  • 12. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [Abstract] [Full Text] [Related]

  • 13. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M, Sharifi N, Fritsche HM, Aziz A, Miller F, Kluth LA, Ngamsri T, Dahlem R, Chun FK, Shariat SF, Stenzl A, Fisch M, Gakis G.
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
    Sung HH, Jeon HG, Han DH, Jeong BC, Seo SI, Lee HM, Choi HY, Jeon SS.
    PLoS One; 2015 Feb; 10(11):e0139976. PubMed ID: 26556239
    [Abstract] [Full Text] [Related]

  • 15. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
    Grasso M, Fishman AI, Cohen J, Alexander B.
    BJU Int; 2012 Dec; 110(11):1618-26. PubMed ID: 22458598
    [Abstract] [Full Text] [Related]

  • 16. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF, Upper Tract Urothelial Carcinoma Collaboration.
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma.
    Youssef RF, Krabbe LM, Shariat SF, Lotan Y, Sagalowsky AI, Raman J, Wood CG, Weizer A, Roscigno M, Montorsi F, Bolenz C, Remzi M, Bensalah K, Kassouf W, Margulis V.
    World J Urol; 2015 Dec; 33(12):1965-72. PubMed ID: 25957592
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.